Efficacy and Safety Study of Two Propofol Formulations

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study to compare Propofol-MCT/LCT with LCT in terms of their efficacy and safety during total intravenous anaesthesia

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: B. Braun Melsungen AG
• Collaborators: B. Braun Medical International Trading Company Ltd.; Tigermed Consulting Co., Ltd
• Treatments: Propofol

Criteria

Inclusion Criteria:

• Female and male adult patients, and at least 18 and maximal 65 years of age;

• ASA-classification I to II;

• Undergoing an elective surgery, the anaesthesia is expected to last at least 1 hour and no more than 3 hours;

• Will be under total intravenous anaesthesia;

• Willing to give their signed informed consent.